Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MITIGATE-HD
NCT01458470Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Sep 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in Huntington disease (HD), sponsored by University of British Columbia. Started Sep 2011; status: completed.
02
Drugs
memantine
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on NCT01458470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458470.